Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07031141

Diabetes Foot Africa Region Registry

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
Getz Pharma · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

D-FAR is to gather robust data on the clinical characteristics, management, and outcomes of patients with diabetic foot complications to enhance understanding, reduce complications, and improve patient care. This will include insights into the prevalence of risk factors, adherence to treatment protocols, and the effectiveness of interventions aimed at reducing the incidence of amputations and other adverse outcomes.

Detailed description

Among the various complications, those related to diabetic foot disease are associated with the highest morbidity and mortality. Diabetic foot problems are characterized by infection, ulceration and/or destruction of deep tissue in the foot and are usually associated with neurological abnormalities and varying degrees of peripheral arterial disease (PAD) in the lower limb. the purpose of collect comprehensive data on the clinical features, management strategies, and outcomes of patients with diabetic foot complications.

Conditions

Timeline

Start date
2025-08-01
Primary completion
2027-02-01
Completion
2027-02-01
First posted
2025-06-22
Last updated
2025-06-22

Source: ClinicalTrials.gov record NCT07031141. Inclusion in this directory is not an endorsement.

Diabetes Foot Africa Region Registry (NCT07031141) · Clinical Trials Directory